While companies like DeepSeek may find success in certain market segments, they face an uphill battle against this massive ...

The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Study urges industry to be more transparent and fairer in selecting speakers, and to recruit more women to steering ...

Pfizer will pay $60 million to settle allegations that one of its subsidiaries incentivized healthcare providers to prescribe ...

David Werner Real Estate Investments and Metro Loft are planning to turn the 33-story tower and neighboring building into ...

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Following a tough opening salvo from Starboard Value last fall, Pfizer is getting a chance to catch its breath in the ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for ...

Pfizer Inc (NYSE:PFE) shares are trading higher Monday. Some of the optimism may be surrounding activist Starboard Value's ...